AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31342499 — intervention group
Group type: COMPARATOR
Intervention: Routine dialysis treatment and nursing care
Number of subjects: 40
Study 29308579 — intervention group
Group type: EXPERIMENTAL
Intervention: Interrupted rapid eye movement sleep
Number of subjects: 90
Study 29308579 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study 26369882 — intervention group
Group type: EXPERIMENTAL
Intervention: Housing First fidelity ratings
Number of subjects: 1158
Study 26369882 — intervention group
Group type: COMPARATOR
Intervention: Program operation measures
Number of subjects: 1158
Study 24553478 — intervention group
Group type: EXPERIMENTAL
Intervention: PNS preceded by nerve localization using a pen device (pen + group)
Number of subjects: 60
Study 24553478 — intervention group
Group type: COMPARATOR
Intervention: PNS alone (pen - group)
Number of subjects: 60
Study 24553478 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (pen + and pen -)
Number of subjects: 60
Study 23730808 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training + Testosterone (50-100 mg/d)
Number of subjects: 68
Study 23730808 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training + Placebo
Number of subjects: 68
Study 23730808 — intervention group
Group type: COMPARATOR
Intervention: Testosterone only (50-100 mg/d)
Number of subjects: 68
Study 23730808 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study 20884494 — intervention group
Group type: EXPERIMENTAL
Intervention: High training accuracy (85% correct) with feedback
Number of subjects: 0
Study 20884494 — intervention group
Group type: COMPARATOR
Intervention: High training accuracy (85% correct) without feedback
Number of subjects: 0
Study 20884494 — intervention group
Group type: EXPERIMENTAL
Intervention: Low training accuracy (65%) with feedback
Number of subjects: 0
Study 20884494 — intervention group
Group type: COMPARATOR
Intervention: Low training accuracy (65%) without feedback
Number of subjects: 0
Study 27950573 — intervention group
Group type: COMPARATOR
Intervention: Concurrent chemoradiation (CRT)
Number of subjects: 222
Study 27950573 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant chemotherapy (AC)
Number of subjects: 222
Study 27950573 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy (RT)
Number of subjects: 222
Study 27950573 — intervention group
Group type: EXPERIMENTAL
Intervention: RT + AC
Number of subjects: 222
Study 27950573 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT + AC
Number of subjects: 222
Study 16029381 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine at 2 mcg/min
Number of subjects: 43
Study 16029381 — intervention group
Group type: EXPERIMENTAL
Intervention: Norepinephrine at 2 mcg/min
Number of subjects: 43
Study 16029381 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 16029381 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blockers
Number of subjects: 43
Study 12810609 — intervention group
Group type: EXPERIMENTAL
Intervention: New-onset T1DM (group A)
Number of subjects: 46
Study 12810609 — intervention group
Group type: EXPERIMENTAL
Intervention: Re-examination after 12 months (group A)
Number of subjects: 46
Study 12810609 — intervention group
Group type: COMPARATOR
Intervention: Stable disease (group B)
Number of subjects: 46
Study 11379447 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice-based ORS
Number of subjects: 88
Study 11379447 — intervention group
Group type: EXPERIMENTAL
Intervention: Maize-based ORS
Number of subjects: 88
Study 8862721 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone 250 mg
Number of subjects: 60
Study 8862721 — intervention group
Group type: COMPARATOR
Intervention: Methylprednisolone 40 mg
Number of subjects: 60
Study 1480253 — intervention group
Group type: EXPERIMENTAL
Intervention: Mammographic screening before the age of 50
Number of subjects: 0
Study 1480253 — intervention group
Group type: COMPARATOR
Intervention: No screening (implied control)
Number of subjects: 0
Study 3777828 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastrojejunostomy
Number of subjects: 22
Study 3777828 — intervention group
Group type: COMPARATOR
Intervention: Gastroduodenostomy (Billroth I)
Number of subjects: 22
Study 3777828 — intervention group
Group type: COMPARATOR
Intervention: Preoperative patients
Number of subjects: 22
Study 29499972 — intervention group
Group type: EXPERIMENTAL
Intervention: MUFA
Number of subjects: 13
Study 29499972 — intervention group
Group type: EXPERIMENTAL
Intervention: SMCSFA
Number of subjects: 13
Study 29499972 — intervention group
Group type: EXPERIMENTAL
Intervention: LCSFA
Number of subjects: 13
Study 27930697 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediction model based on clinical and anthropometric variables
Number of subjects: 1303
Study 27930697 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediction model with addition of candidate biomarkers
Number of subjects: 1303
Study 27930697 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediction model with addition of NMR metabolites
Number of subjects: 1303
Study 27930697 — intervention group
Group type: EXPERIMENTAL
Intervention: Models using a ≥35% risk threshold
Number of subjects: 1303
Study 24862166 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate delivery
Number of subjects: 723
Study 24862166 — intervention group
Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 723
Study 24862166 — intervention group
Group type: EXPERIMENTAL
Intervention: Inducing labour only in GBS-positive women
Number of subjects: 723
Study 23207855 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory chain (MC)
Number of subjects: 13
Study 23207855 — intervention group
Group type: EXPERIMENTAL
Intervention: Super slick chain (SSC)
Number of subjects: 13
Study 23207855 — intervention group
Group type: COMPARATOR
Intervention: Plastic chain (PC)
Number of subjects: 13
Study 20185164 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostacyclin analogue (PGI)
Number of subjects: 23
Study 20185164 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH)
Number of subjects: 23
Study 16199835 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 533
Study 16199835 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 533
Study 16199835 — intervention group
Group type: COMPARATOR
Intervention: Risperidone vs Haloperidol
Number of subjects: 533
Study 12874742 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral kilocalorie and protein supplementation for 3 months (treatment group)
Number of subjects: 117
Study 12874742 — intervention group
Group type: COMPARATOR
Intervention: No intervention (low-risk group)
Number of subjects: 117
Study 12874742 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral kilocalorie and protein supplementation (treatment group)
Number of subjects: 117
Study 10776134 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaching Method 1
Number of subjects: 0
Study 10776134 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaching Method 2
Number of subjects: 0
Study 10776134 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaching Method 3
Number of subjects: 0
Study 8539676 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with limb girdle dystrophy
Number of subjects: 15
Study 8539676 — intervention group
Group type: COMPARATOR
Intervention: Control group (age-matched normal group)
Number of subjects: 15
Study 2146231 — intervention group
Group type: EXPERIMENTAL
Intervention: Trospectomycin 250 mg
Number of subjects: 30
Study 2146231 — intervention group
Group type: EXPERIMENTAL
Intervention: Trospectomycin 500 mg
Number of subjects: 30
Study 2146231 — intervention group
Group type: EXPERIMENTAL
Intervention: Trospectomycin 750 mg
Number of subjects: 30
Study 2146231 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 30
Study 589769 — intervention group
Group type: EXPERIMENTAL
Intervention: D. pteronyssinus extract
Number of subjects: 66
Study 589769 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 31931884 — intervention group
Group type: EXPERIMENTAL
Intervention: LINC‐II intervention (strengths‐based HIV case management, rapid ART initiation, pharmacotherapy for opioid use disorder)
Number of subjects: 240
Study 31931884 — intervention group
Group type: EXPERIMENTAL
Intervention: LINC‐II intervention
Number of subjects: 240
Study 30797396 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-delivered brief intervention (CBI)
Number of subjects: 237
Study 27865630 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 8mg + Nimesulide 100mg
Number of subjects: 40
Study 27865630 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone + Placebo
Number of subjects: 40
Study 25216791 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed suction drainage (CSD)
Number of subjects: 51
Study 23454066 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fidelity patient simulator
Number of subjects: 86
Study 23454066 — intervention group
Group type: EXPERIMENTAL
Intervention: Static mannequin
Number of subjects: 86
Study 23454066 — intervention group
Group type: EXPERIMENTAL
Intervention: Paper/pencil case study
Number of subjects: 86
Study 23454066 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 86
Study 21672252 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided Self-Determination-Young (GSD-Y) intervention during 8 outpatient visits
Number of subjects: 68
Study 21672252 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided Self-Determination-Young (GSD-Y) intervention
Number of subjects: 68
Study 21672252 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving standard visits
Number of subjects: 68
Study 19148448 — intervention group
Group type: EXPERIMENTAL
Intervention: Apicectomy and root canal obturation completed one time under direct vision (Group A)
Number of subjects: 34
Study 19148448 — intervention group
Group type: COMPARATOR
Intervention: Apicectomy done after RCT (Group B)
Number of subjects: 34
Study 15921866 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan (16 mg/d)
Number of subjects: 29
Study 15921866 — intervention group
Group type: COMPARATOR
Intervention: Felodipine (5 mg/d)
Number of subjects: 29
Study 15921866 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 15921866 — intervention group
Group type: COMPARATOR
Intervention: Nitroglycerin
Number of subjects: 29
Study 15921866 — intervention group
Group type: COMPARATOR
Intervention: Basal FBF
Number of subjects: 29
Study 12576119 — intervention group
Group type: EXPERIMENTAL
Intervention: Deprived conditions
Number of subjects: 17
Study 12576119 — intervention group
Group type: COMPARATOR
Intervention: Fed conditions
Number of subjects: 17
Study 10832765 — intervention group
Group type: EXPERIMENTAL
Intervention: Phentermine (PHE)
Number of subjects: 22
Study 10832765 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibutramine (SIB)
Number of subjects: 22
Study 10832765 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexfenfluramine
Number of subjects: 22
Study 10832765 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 9110007 — intervention group
Group type: EXPERIMENTAL
Intervention: IV ketorolac (1 mg/kg)
Number of subjects: 34
Study 9110007 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 34
Study 8268432 — intervention group
Group type: EXPERIMENTAL
Intervention: Disconnection of the ventilatory system
Number of subjects: 712
Study 8268432 — intervention group
Group type: COMPARATOR
Intervention: Continuation of the ventilatory system
Number of subjects: 712
Study 8268432 — intervention group
Group type: COMPARATOR
Intervention: Positive end-expiratory pressure
Number of subjects: 712
Study 8268432 — intervention group
Group type: COMPARATOR
Intervention: Chronic obstructive pulmonary disease
Number of subjects: 712
Study 8268432 — intervention group
Group type: COMPARATOR
Intervention: Surgeon-related risk factor
Number of subjects: 712
Study 3543161 — intervention group
Group type: EXPERIMENTAL
Intervention: Acedapsone (3 injections at 10 weeks interval)
Number of subjects: 560
Study 3543161 — intervention group
Group type: COMPARATOR
Intervention: Placebo (3 injections at 10 weeks interval)
Number of subjects: 560
Study 3543161 — intervention group
Group type: EXPERIMENTAL
Intervention: Acedapsone
Number of subjects: 560
Study 29362929 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal ADHD treatment (group psychotherapy plus methylphenidate)
Number of subjects: 125
Study 29362929 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-child training (PCT) program
Number of subjects: 125
Study 29362929 — intervention group
Group type: COMPARATOR
Intervention: Clinical management (mainly supportive counselling)
Number of subjects: 125
Study 25860822 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental Practice (MP) for 20 minutes
Number of subjects: 78
Study 25860822 — intervention group
Group type: COMPARATOR
Intervention: Advanced Trauma Life Support (ATLS) training for 20 minutes
Number of subjects: 78
Study 25523036 — intervention group
Group type: EXPERIMENTAL
Intervention: ORAL IMPACT® (preoperative oral immunonutrition)
Number of subjects: 400
Study 25523036 — intervention group
Group type: COMPARATOR
Intervention: IMPACT CONTROL® (isocaloric isonitrogenous supplement)
Number of subjects: 400
Study 21880080 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyethylene glycol (PEG)
Number of subjects: 348
Study 21880080 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium picosulphate (SPS)
Number of subjects: 348
Study 21880080 — intervention group
Group type: COMPARATOR
Intervention: Lactulose (L)
Number of subjects: 348
Study 20075788 — intervention group
Group type: EXPERIMENTAL
Intervention: Basiliximab
Number of subjects: 212
Study 20075788 — intervention group
Group type: EXPERIMENTAL
Intervention: Daclizumab
Number of subjects: 212
Study 18296130 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive granulocyte and monocyte adsorption (GMA) with Adacolumn, 2 sessions/week for 3 weeks, then 1 session/week for up to 11 sessions (n = 35)
Number of subjects: 70
Study 18296130 — intervention group
Group type: COMPARATOR
Intervention: Intravenous prednisolone, 40-60 mg/day for 5-10 days (n = 35)
Number of subjects: 70
Study 16158009 — intervention group
Group type: EXPERIMENTAL
Intervention: DemTect cutoff score of ≤11 points for DAT
Number of subjects: 38
Study 16158009 — intervention group
Group type: EXPERIMENTAL
Intervention: DemTect cutoff score of ≤13 points for MCI
Number of subjects: 38
Study 16158009 — intervention group
Group type: EXPERIMENTAL
Intervention: DemTect cutoff score of ≤13 points for AD-typical patterns of cerebral glucose metabolism
Number of subjects: 38
Study 11843742 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal PCA diamorphine (1.0 mg bolus, 3 min lockout)
Number of subjects: 52
Study 11843742 — intervention group
Group type: COMPARATOR
Intervention: Intravenous PCA diamorphine (0.5 mg bolus, 3 min lockout)
Number of subjects: 52
Study 10399792 — intervention group
Group type: EXPERIMENTAL
Intervention: Sarcoidosis patients with sicca symptoms
Number of subjects: 12
Study 10399792 — intervention group
Group type: EXPERIMENTAL
Intervention: Sarcoidosis patients
Number of subjects: 12
Study 10399792 — intervention group
Group type: COMPARATOR
Intervention: Sjögren's syndrome patients
Number of subjects: 12
Study 7742578 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporin alone (CsA group, n = 10)
Number of subjects: 22
Study 7742578 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine-prednisone (AzP group, n = 12)
Number of subjects: 22
Study 7742578 — intervention group
Group type: COMPARATOR
Intervention: Both CsA and AzP groups combined
Number of subjects: 22
Study 2258784 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 0
Study 2258784 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 0
Study 6270978 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone scintigraphy
Number of subjects: 387
Study 6270978 — intervention group
Group type: COMPARATOR
Intervention: No bone scintigraphy
Number of subjects: 387
Study 30621718 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised multidisciplinary intervention (n=59)
Number of subjects: 119
Study 30621718 — intervention group
Group type: COMPARATOR
Intervention: Standard management (n=60)
Number of subjects: 119
Study 29667211 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib 100-200 mg b.d.
Number of subjects: 24081
Study 29667211 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen 600-800 mg t.d.s.
Number of subjects: 24081
Study 29667211 — intervention group
Group type: COMPARATOR
Intervention: Naproxen 375-500 mg b.d.
Number of subjects: 24081
Study 27440562 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior approach
Number of subjects: 32
Study 27440562 — intervention group
Group type: COMPARATOR
Intervention: Anterior approach
Number of subjects: 32
Study 27440562 — intervention group
Group type: EXPERIMENTAL
Intervention: Anatomic reinsertion of the ruptured tendon
Number of subjects: 32
Study 27440562 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited supinator muscle fat content
Number of subjects: 32
Study 24251955 — intervention group
Group type: EXPERIMENTAL
Intervention: Mother's scent
Number of subjects: 97
Study 24251955 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexion position
Number of subjects: 97
Study 24251955 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 97
Study 21718964 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure-relief mattress
Number of subjects: 12
Study 21718964 — intervention group
Group type: COMPARATOR
Intervention: Conventional mattress
Number of subjects: 12
Study 20716305 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg per week of oral naltrexone plus standard psychosocial treatment as usual (n = 56)
Number of subjects: 111
Study 20716305 — intervention group
Group type: COMPARATOR
Intervention: Standard psychosocial treatment as usual (TAU) without naltrexone (n = 55)
Number of subjects: 111
Study 17563698 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted total knee arthroplasty
Number of subjects: 25
Study 16779027 — intervention group
Group type: EXPERIMENTAL
Intervention: IT evaluation studies
Number of subjects: 64
Study 16779027 — intervention group
Group type: COMPARATOR
Intervention: Randomized controlled trials (RCT)
Number of subjects: 64
Study 16779027 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-centre studies
Number of subjects: 64
Study 16779027 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of evaluation studies
Number of subjects: 64
Study 12021498 — intervention group
Group type: EXPERIMENTAL
Intervention: Heptavalent pneumococcal CRM 197 conjugate vaccine
Number of subjects: 0
Study 12021498 — intervention group
Group type: EXPERIMENTAL
Intervention: Influenza vaccines
Number of subjects: 0
Study 12021498 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive immunoprophylaxis
Number of subjects: 0
Study 12021498 — intervention group
Group type: EXPERIMENTAL
Intervention: Mucosal immunization and DNA/gene technology
Number of subjects: 0
Study 9042984 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine 10 mg
Number of subjects: 366
Study 9042984 — intervention group
Group type: COMPARATOR
Intervention: Alginate (2 x 250 mg chewable tablets)
Number of subjects: 366
Study 7836717 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccine (four doses)
Number of subjects: 68
Study 2856596 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin ethylsuccinate
Number of subjects: 265
Study 2856596 — intervention group
Group type: COMPARATOR
Intervention: Enteric‐coated erythromycin
Number of subjects: 265
Study 29550020 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical dipyrone gel
Number of subjects: 120
Study 29550020 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 120
Study 27056738 — intervention group
Group type: EXPERIMENTAL
Intervention: ABC-bleeding score (age, biomarkers [GDF-15, cTnT-hs, haemoglobin], clinical history [previous bleeding])
Number of subjects: 22505
Study 27056738 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified ABC-bleeding score using alternative biomarkers (haematocrit, cTnI-hs, cystatin C, or creatinine clearance)
Number of subjects: 22505
Study 24771090 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal insulin glargine
Number of subjects: 12537
Study 24771090 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 12537
Study 22858703 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-etch bond (SeB)
Number of subjects: 35
Study 22858703 — intervention group
Group type: COMPARATOR
Intervention: Single Bond (SB)
Number of subjects: 35
Study 20158586 — intervention group
Group type: EXPERIMENTAL
Intervention: sulfasalazine (maximum 2.5 g/day)
Number of subjects: 52
Study 20158586 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 52
Study 20158586 — intervention group
Group type: EXPERIMENTAL
Intervention: sulfasalazine
Number of subjects: 52
Study 18375786 — intervention group
Group type: EXPERIMENTAL
Intervention: Sectioning of the conoid ligament
Number of subjects: 40
Study 18375786 — intervention group
Group type: EXPERIMENTAL
Intervention: Sectioning of the trapezoid ligament
Number of subjects: 40
Study 18375786 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete acromioclavicular joint injury with partial disruption of the coracoclavicular ligament complex
Number of subjects: 40
Study 17012867 — intervention group
Group type: EXPERIMENTAL
Intervention: Yellow fever 17D vaccine
Number of subjects: 43532
Study 15107935 — intervention group
Group type: EXPERIMENTAL
Intervention: VACOP-B for 6 weeks plus involved field radiotherapy (Stage I)
Number of subjects: 93
Study 15107935 — intervention group
Group type: EXPERIMENTAL
Intervention: VACOP-B for 12 weeks plus involved field radiotherapy on residual masses (Stage II)
Number of subjects: 93
Study 11783327 — intervention group
Group type: EXPERIMENTAL
Intervention: HANS plus small dose of buprenorphine (BPN)
Number of subjects: 33
Study 11783327 — intervention group
Group type: COMPARATOR
Intervention: BPN
Number of subjects: 33
Study 9595795 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen administration by nasal cannula during the first or second postoperative night
Number of subjects: 15
Study 9595795 — intervention group
Group type: COMPARATOR
Intervention: No oxygen therapy (control group)
Number of subjects: 15
Study 8357297 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam (titrated upward to reach 6.0 mg/d)
Number of subjects: 237